https://news.medxy.ai/zh/83520-2/Medxy AIzh2026-10-12T03:18:17-07:00丝蛋白-透明质酸喉成形术：评估其治疗声门闭合不全的安全性和有效性 https://news.medxy.ai/ja/silk-protein-hyaluronic-laryngoplasty/Medxy AIja2026-10-12T03:17:59-07:00シルク蛋白-ヒアルロン酸喉頭形成術：声門不全に対する安全性と有効性の検証 https://news.medxy.ai/vi/silk-hyaluronic-acid/Medxy AIvi2026-10-12T03:17:41-07:00Tạo Hình Thanh Quản Silk-Hyaluronic Acid: Đánh Giá Tính An Toàn Và Hiệu Quả Trong Điều Trị Hở Thanh Môn https://news.medxy.ai/silk-hyaluronic-acid-laryngoplasty-evaluating-safety-and-efficacy-in-treating-glottic-insufficiency/Medxy AIen2026-10-12T03:17:19-07:00Silk-Hyaluronic Acid Laryngoplasty: Evaluating Safety and Efficacy in Treating Glottic Insufficiency https://news.medxy.ai/zh/appendicitis-antibiotics/Medxy AIzh2026-10-12T03:16:43-07:00急性阑尾炎阑尾切除术后抗生素是否仍需常规使用？一项大型回顾性研究的再审视 https://news.medxy.ai/ja/appendectomy-antibiotics-need/Medxy AIja2026-10-12T03:16:20-07:00急性虫垂炎の虫垂切除術後に抗菌薬は本当に必要か：大規模後ろ向き研究からの示唆 https://news.medxy.ai/vi/antibiotics-after-appendectomy/Medxy AIvi2026-10-12T03:15:57-07:00Kháng sinh sau cắt ruột thừa ở viêm ruột thừa cấp: Có cần dùng thường quy không? Bằng chứng từ một nghiên cứu hồi cứu quy mô lớn https://news.medxy.ai/reevaluating-postoperative-antibiotic-use-after-appendectomy-in-acute-appendicitis-insights-from-a-large-retrospective-study/Medxy AIen2026-10-12T03:15:35-07:00Reevaluating Postoperative Antibiotic Use After Appendectomy in Acute Appendicitis: Insights from a Large Retrospective Study https://news.medxy.ai/ja/ivf-multiple-pregnancy-reduction/Medxy AIja2026-10-12T03:14:56-07:00IVF後の多胎妊娠を減らすには：RCOG Scientific Impact Paper No.22 第3版（2026）に基づく実践ガイド https://news.medxy.ai/vi/83501-2/Medxy AIvi2026-10-12T03:14:23-07:00Giảm thiểu tình trạng đa thai sau thụ tinh trong ống nghiệm (IVF): Tài liệu về Tác động Khoa học số 22 của RCOG (Ấn bản lần thứ 3, 2026) – Hướng dẫn thực hành https://news.medxy.ai/zh/reduce-ivf-multiple-pregnancy/Medxy AIzh2026-10-12T03:13:52-07:00降低IVF后的多胎妊娠：RCOG第22号Scientific Impact Paper（第3版，2026）实用指南 https://news.medxy.ai/reducing-multiple-pregnancies-after-ivf-practical-guidance-from-rcog-scientific-impact-paper-no-22-3rd-ed-2026/Medxy AIen2026-10-12T03:13:23-07:00Reducing Multiple Pregnancies After IVF: Practical Guidance from RCOG Scientific Impact Paper No.22 (3rd Ed., 2026) https://news.medxy.ai/zh/child-varices-outcome/Medxy AIzh2026-10-12T03:12:15-07:00儿童首次静脉曲张出血后的结局与死亡率：来自全球多中心研究的启示 https://news.medxy.ai/ja/pediatric-variceal-bleeding/Medxy AIja2026-10-12T03:11:54-07:00小児初回静脈瘤出血後の転帰と死亡率：国際多施設研究から得られた知見 https://news.medxy.ai/vi/83489-2/Medxy AIvi2026-10-12T03:11:31-07:00Kết cục và tỷ lệ tử vong sau đợt xuất huyết do giãn tĩnh mạch lần đầu ở trẻ em https://news.medxy.ai/outcomes-and-mortality-after-pediatric-first-variceal-hemorrhage-insights-from-a-global-multicenter-study/Medxy AIen2026-10-12T03:11:08-07:00Outcomes and Mortality After Pediatric First Variceal Hemorrhage: Insights from a Global Multicenter Study https://news.medxy.ai/ja/parkinsons-physical-activity/Medxy AIja2026-10-12T03:10:24-07:00パーキンソン病の運動・認知機能進行に対する身体活動の影響：縦断コホート研究 https://news.medxy.ai/vi/physical-activity-parkinsons/Medxy AIvi2026-10-12T03:10:04-07:00Hoạt động thể chất liên quan thế nào đến tiến triển vận động và nhận thức ở bệnh Parkinson? Kết quả từ một nghiên cứu đoàn hệ theo dõi dọc https://news.medxy.ai/physical-activity-and-motor-and-cognitive-progression-in-parkinson-disease-a-longitudinal-cohort-study/Medxy AIen2026-10-12T03:09:46-07:00Physical Activity and Motor and Cognitive Progression in Parkinson Disease: A Longitudinal Cohort Study https://news.medxy.ai/zh/polygenic-risk-lifestyle-diabetes/Medxy AIzh2026-10-12T03:09:11-07:00整合多基因风险评分与生活方式因素：预测日本人群2型糖尿病发生的新思路 https://news.medxy.ai/ja/type-2-diabetes-risk-japan/Medxy AIja2026-10-12T03:08:52-07:00日本人における2型糖尿病発症予測：多遺伝子リスクスコアと生活習慣因子の統合 https://news.medxy.ai/vi/type-2-diabetes-risk/Medxy AIvi2026-10-12T03:08:30-07:00Kết hợp điểm nguy cơ đa gen và yếu tố lối sống để dự đoán khởi phát đái tháo đường type 2 ở người Nhật https://news.medxy.ai/integrating-polygenic-risk-scores-and-lifestyle-factors-to-predict-type-2-diabetes-onset-in-the-japanese-population/Medxy AIen2026-10-12T03:08:07-07:00Integrating Polygenic Risk Scores and Lifestyle Factors to Predict Type 2 Diabetes Onset in the Japanese Population https://news.medxy.ai/zh/otc-painkillers-concussion/Medxy AIzh2026-10-12T03:07:30-07:00非处方镇痛药对脑震荡恢复的影响：CARE 联合体研究带来的启示 https://news.medxy.ai/ja/over-the-counter-painkillers/Medxy AIja2026-10-12T03:07:13-07:00脳震盪回復における市販鎮痛薬の影響：CARE Consortium研究から得られた知見 https://news.medxy.ai/vi/otc-painkillers-recovery/Medxy AIvi2026-10-12T03:06:43-07:00Tác động của thuốc giảm đau không kê đơn lên quá trình hồi phục sau chấn động não: những phát hiện từ nghiên cứu CARE Consortium https://news.medxy.ai/impact-of-otc-analgesics-on-concussion-recovery-insights-from-the-care-consortium-study/Medxy AIen2026-10-12T03:06:22-07:00Impact of OTC Analgesics on Concussion Recovery: Insights from the CARE Consortium Study https://news.medxy.ai/zh/ethiopia-stroke-falls/Medxy AIzh2026-10-12T03:05:46-07:00埃塞俄比亚卒中幸存者跌倒相关损伤负担沉重：阿姆哈拉州多中心研究揭示关键风险因素 https://news.medxy.ai/ja/stroke-fall-injuries-ethiopia/Medxy AIja2026-10-12T03:05:28-07:00エチオピアの脳卒中サバイバーにおける転倒関連損傷の高負担：アムハラ州多施設研究からの示唆 https://news.medxy.ai/vi/stroke-fall-burden/Medxy AIvi2026-10-12T03:05:08-07:00Gánh nặng chấn thương do té ngã ở người sống sót sau đột quỵ tại Ethiopia: Kết quả từ một nghiên cứu đa trung tâm ở vùng Amhara https://news.medxy.ai/high-burden-of-fall-related-injuries-among-stroke-survivors-in-ethiopia-insights-from-a-multicenter-study-in-amhara-region/Medxy AIen2026-10-12T03:04:46-07:00High Burden of Fall-Related Injuries Among Stroke Survivors in Ethiopia: Insights from a Multicenter Study in Amhara Region https://news.medxy.ai/zh/tongue-development-immunity/Medxy AIzh2026-10-12T03:04:07-07:00舌部发育不良的免疫谱：识别高风险患者的生物标志物 https://news.medxy.ai/ja/immune-profiling-tongue/Medxy AIja2026-10-12T03:03:47-07:00舌可動部異形成における免疫プロファイリング：高リスク患者を層別化するバイオマーカーの同定 https://news.medxy.ai/vi/immune-profile-tongue-dysplasia/Medxy AIvi2026-10-12T03:03:24-07:00Hồ sơ miễn dịch trong loạn sản lưỡi mặt bụng: Tìm kiếm các dấu ấn sinh học để phân tầng bệnh nhân nguy cơ cao https://news.medxy.ai/immune-profiling-in-oral-tongue-dysplasia-identifying-biomarkers-to-stratify-high-risk-patients/Medxy AIen2026-10-12T03:03:07-07:00Immune Profiling in Oral Tongue Dysplasia: Identifying Biomarkers to Stratify High-Risk Patients https://news.medxy.ai/zh/vision-restoration-progress/Medxy AIzh2026-10-12T03:02:25-07:00视功能修复新进展：光遗传学治疗为视网膜色素变性患者带来希望 https://news.medxy.ai/ja/83440-2/Medxy AIja2026-10-12T03:02:07-07:00視機能回復の新たな進展：光遺伝学治療が網膜色素変性症の患者に希望をもたらす https://news.medxy.ai/vi/gene-therapy-retinitis-pigmentosa/Medxy AIvi2026-10-12T03:01:47-07:00Mở ra hy vọng mới cho bệnh nhân viêm sắc tố võng mạc: liệu pháp quang di truyền cho thấy triển vọng phục hồi thị lực https://news.medxy.ai/advancing-vision-optogenetic-therapy-offers-hope-for-retinitis-pigmentosa-patients/Medxy AIen2026-10-12T03:01:29-07:00Advancing Vision: Optogenetic Therapy Offers Hope for Retinitis Pigmentosa Patients https://news.medxy.ai/zh/venetoclax-cll-prognosis/Medxy AIzh2026-10-11T03:53:31-07:00Venetoclax一线治疗背景下慢性淋巴细胞白血病端粒长度的预后意义 https://news.medxy.ai/ja/83256-2/Medxy AIja2026-10-11T03:53:13-07:00ベネトクラクスによる一次治療下における慢性リンパ球性白血病のテロメア長が持つ予後学的意義 https://news.medxy.ai/vi/83255-2/Medxy AIvi2026-10-11T03:52:51-07:00Ý nghĩa tiên lượng của chiều dài telomere trong bệnh bạch cầu lympho mạn tính được điều trị bằng venetoclax ở bước một https://news.medxy.ai/prognostic-significance-of-telomere-length-in-chronic-lymphocytic-leukemia-under-venetoclax-based-first-line-therapy/Medxy AIen2026-10-11T03:52:30-07:00Prognostic Significance of Telomere Length in Chronic Lymphocytic Leukemia Under Venetoclax-Based First-Line Therapy https://news.medxy.ai/zh/83252-2/Medxy AIzh2026-10-11T03:51:41-07:00Glofitamab 联合 Polatuzumab-R-CHP 治疗初诊弥漫大 B 细胞淋巴瘤展现出卓越疗效与安全性：一项多中心 II 期研究 https://news.medxy.ai/ja/83251-2/Medxy AIja2026-10-11T03:51:25-07:00新規診断されたびまん性大細胞型B細胞リンパ腫におけるグロフィタマブとポラツズマブ-R-CHPの併用療法の優れた有効性と安全性：多施設共同第II相試験 https://news.medxy.ai/vi/glofitamab-safety-efficacy/Medxy AIvi2026-10-11T03:51:07-07:00Hiệu quả và độ an toàn nổi bật của glofitamab phối hợp polatuzumab-R-CHP trong u lympho tế bào B lớn lan tỏa mới chẩn đoán: Nghiên cứu đa trung tâm pha II https://news.medxy.ai/high-efficacy-and-safety-of-glofitamab-plus-polatuzumab-r-chp-in-newly-diagnosed-diffuse-large-b-cell-lymphoma-a-phase-ii-multicenter-study/Medxy AIen2026-10-11T03:50:49-07:00High Efficacy and Safety of Glofitamab Plus Polatuzumab-R-CHP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Multicenter Study https://news.medxy.ai/zh/ziftomenib-venetoclax-azacitidine-treatment/Medxy AIzh2026-10-11T03:50:03-07:00Ziftomenib联合Venetoclax与Azacitidine治疗复发/难治性NPM1突变急性髓系白血病：疗效与安全性分析 https://news.medxy.ai/ja/npm1-leukemia-therapy/Medxy AIja2026-10-11T03:49:44-07:00再発／難治性NPM1変異急性骨髄性白血病におけるZiftomenibとVenetoclax・Azacitidine併用療法の有効性と安全性 https://news.medxy.ai/vi/ziftomenib-venetoclax-azacitidine/Medxy AIvi2026-10-11T03:49:24-07:00Ziftomenib phối hợp venetoclax và azacitidine: hiệu quả và độ an toàn đầy hứa hẹn trong AML đột biến NPM1 tái phát/kháng trị https://news.medxy.ai/efficacy-and-safety-of-ziftomenib-combined-with-venetoclax-and-azacitidine-in-relapsed-refractory-npm1-mutated-acute-myeloid-leukemia/Medxy AIen2026-10-11T03:49:04-07:00Efficacy and Safety of Ziftomenib Combined with Venetoclax and Azacitidine in Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia https://news.medxy.ai/zh/icu-pharmacist-workload/Medxy AIzh2026-10-11T03:48:23-07:00优化 ICU 药师工作负荷：对患者死亡率与用药管理的影响 https://news.medxy.ai/ja/83228-2/Medxy AIja2026-10-11T03:48:08-07:00ICU薬剤師の業務量最適化：患者の死亡率および薬剤管理への影響 https://news.medxy.ai/vi/icu-pharmacist-workload-2/Medxy AIvi2026-10-11T03:47:49-07:00Tối ưu hóa khối lượng công việc của dược sĩ ICU: Tác động đến tử vong người bệnh và quản lý thuốc https://news.medxy.ai/optimizing-icu-pharmacist-workload-impact-on-patient-mortality-and-medication-management/Medxy AIen2026-10-11T03:47:32-07:00Optimizing ICU Pharmacist Workload: Impact on Patient Mortality and Medication Management https://news.medxy.ai/zh/biologics-severe-asthma/Medxy AIzh2026-10-11T03:46:54-07:00生物制剂适用重症哮喘的加重轨迹：来自英国全国数据的启示 https://news.medxy.ai/ja/severe-asthma-exacerbations/Medxy AIja2026-10-11T03:46:36-07:00生物学的製剤適応の重症喘息における増悪経過：英国全国データが示す新知見 https://news.medxy.ai/vi/severe-asthma-biology/Medxy AIvi2026-10-11T03:46:17-07:00Quỹ đạo kịch phát ở hen phế quản nặng đủ điều kiện điều trị sinh học: góc nhìn từ dữ liệu toàn quốc Vương quốc Anh https://news.medxy.ai/trajectory-of-exacerbations-in-biologic-eligible-severe-asthma-insights-from-uk-nationwide-data/Medxy AIen2026-10-11T03:45:59-07:00Trajectory of Exacerbations in Biologic-Eligible Severe Asthma: Insights from UK Nationwide Data https://news.medxy.ai/zh/pediatric-pulmonary-hypertension/Medxy AIzh2026-10-11T03:45:16-07:00儿童肺动脉高压加用sotatercept：Pediatric Pulmonary Hypertension Network带来可喜结果 https://news.medxy.ai/ja/sotatercept-pediatric-hypertension/Medxy AIja2026-10-11T03:44:57-07:00小児肺高血圧症における補助療法としての sotatercept：Pediatric Pulmonary Hypertension Network が示した有望な成績 https://news.medxy.ai/vi/sotatercept-pediatric-ph-therapy/Medxy AIvi2026-10-11T03:44:38-07:00Sotatercept như liệu pháp bổ sung trong tăng áp phổi nhi khoa: Kết quả đầy hứa hẹn từ Pediatric Pulmonary Hypertension Network https://news.medxy.ai/sotatercept-as-add-on-therapy-in-pediatric-pulmonary-hypertension-promising-outcomes-from-the-pediatric-pulmonary-hypertension-network/Medxy AIen2026-10-11T03:44:20-07:00Sotatercept as Add-On Therapy in Pediatric Pulmonary Hypertension: Promising Outcomes from the Pediatric Pulmonary Hypertension Network https://news.medxy.ai/ja/preterm-lung-health/Medxy AIja2026-10-11T03:43:39-07:00早産後の肺健康：生涯にわたる呼吸器ケアに向けた実践的コンセンサス https://news.medxy.ai/vi/lung-health-preterm/Medxy AIvi2026-10-11T03:43:06-07:00Sức khỏe phổi sau sinh non: Đồng thuận thực hành cho chăm sóc hô hấp suốt đời https://news.medxy.ai/zh/preterm-lung-health-2/Medxy AIzh2026-10-11T03:42:34-07:00早产后肺健康：终身呼吸照护的实用共识 https://news.medxy.ai/lung-health-after-preterm-birth-practical-consensus-for-lifelong-respiratory-care/Medxy AIen2026-10-11T03:42:05-07:00Lung Health after Preterm Birth: Practical Consensus for Lifelong Respiratory Care https://news.medxy.ai/zh/83173-2/Medxy AIzh2026-10-11T03:41:02-07:00肠道菌群与特发性肺纤维化：与疾病严重程度及生存转归的关联 https://news.medxy.ai/ja/gut-microbiota-ipf/Medxy AIja2026-10-11T03:40:45-07:00腸内細菌叢と特発性肺線維症：疾患重症度と生存転帰との関連 https://news.medxy.ai/vi/gut-microbiota-ipf-2/Medxy AIvi2026-10-11T03:40:25-07:00Hệ vi sinh vật đường ruột trong xơ phổi vô căn: liên quan với mức độ nặng bệnh và kết cục sống còn https://news.medxy.ai/gut-microbiota-and-idiopathic-pulmonary-fibrosis-associations-with-disease-severity-and-survival-outcomes/Medxy AIen2026-10-11T03:40:06-07:00Gut Microbiota and Idiopathic Pulmonary Fibrosis: Associations with Disease Severity and Survival Outcomes https://news.medxy.ai/zh/telomere-length-ipf/Medxy AIzh2026-10-11T03:39:17-07:00年龄校正全基因组测序端粒长度在特发性肺纤维化中的应用：提升诊断与预后精准度 https://news.medxy.ai/ja/83160-2/Medxy AIja2026-10-11T03:38:59-07:00特発性肺線維症における年齢補正全ゲノムシーケンシング・テロメア長測定の応用：診断および予後予測の精度向上 https://news.medxy.ai/vi/telomere-length-ipf-2/Medxy AIvi2026-10-11T03:38:38-07:00Chiều dài telomere từ giải trình tự toàn bộ hệ gen đã hiệu chỉnh theo tuổi trong xơ phổi vô căn: Nâng cao độ chính xác chẩn đoán và tiên lượng https://news.medxy.ai/age-adjusted-whole-genome-sequencing-telomere-length-in-idiopathic-pulmonary-fibrosis-enhancing-diagnostic-and-prognostic-precision/Medxy AIen2026-10-11T03:38:20-07:00Age-Adjusted Whole Genome Sequencing Telomere Length in Idiopathic Pulmonary Fibrosis: Enhancing Diagnostic and Prognostic Precision https://news.medxy.ai/zh/pcsk9-inhibitors-protection/Medxy AIzh2026-10-11T03:37:40-07:00PCSK9抑制剂在高脂血症患者视网膜血管阻塞预防中的保护作用 https://news.medxy.ai/ja/pcsk9-retinal-protection/Medxy AIja2026-10-11T03:37:23-07:00高脂血症患者におけるPCSK9阻害薬と網膜血管閉塞に対する保護効果 https://news.medxy.ai/vi/pcsk9-inhibitors-retina/Medxy AIvi2026-10-11T03:37:03-07:00Thuốc ức chế PCSK9 và vai trò bảo vệ trước tắc mạch máu võng mạc ở bệnh nhân tăng lipid máu https://news.medxy.ai/pcsk9-inhibitors-and-their-protective-role-against-retinal-vascular-occlusions-in-hyperlipidemic-patients/Medxy AIen2026-10-11T03:36:45-07:00PCSK9 Inhibitors and Their Protective Role Against Retinal Vascular Occlusions in Hyperlipidemic Patients https://news.medxy.ai/zh/virtual-orals-gender-equity/Medxy AIzh2026-10-11T03:36:00-07:00虚拟口试推动眼科学性别公平：美国眼科学委员会考官代表性显著提升 https://news.medxy.ai/ja/gender-equality-ophthalmology/Medxy AIja2026-10-11T03:35:44-07:00眼科学におけるジェンダー平等の前進：オンライン口頭試験が医療人材構成に与える影響 https://news.medxy.ai/vi/gender-equity-ophthalmology/Medxy AIvi2026-10-11T03:35:24-07:00Thúc đẩy công bằng giới trong nhãn khoa: Tác động của kỳ thi vấn đáp trực tuyến đến đại diện nhân lực https://news.medxy.ai/advancing-gender-equity-in-ophthalmology-the-impact-of-virtual-oral-board-exams-on-workforce-representation/Medxy AIen2026-10-11T03:35:09-07:00Advancing Gender Equity in Ophthalmology: The Impact of Virtual Oral Board Exams on Workforce Representation https://news.medxy.ai/zh/personalized-corneal-crosslinking/Medxy AIzh2026-10-11T03:34:30-07:00超薄圆锥角膜的个体化高能量角膜交联：ELZA-sub400 方案带来的启示 https://news.medxy.ai/ja/corneal-crosslinking/Medxy AIja2026-10-11T03:34:10-07:00超薄角膜円錐角膜に対する個別化高フルエンス角膜コラーゲン架橋術：ELZA-sub400プロトコルから得られた知見 https://news.medxy.ai/vi/83123-2/Medxy AIvi2026-10-11T03:33:49-07:00Kỹ thuật liên kết chéo collagen giác mạc cá thể hóa với năng lượng cao (high-fluence) dành cho giác mạc chóp cực mỏng: Những hiểu biết từ quy trình ELZA-sub400 https://news.medxy.ai/individualized-high-fluence-corneal-cross-linking-for-ultrathin-keratoconus-insights-from-the-elza-sub400-protocol/Medxy AIen2026-10-11T03:33:29-07:00Individualized High-Fluence Corneal Cross-Linking for Ultrathin Keratoconus: Insights from the ELZA-sub400 Protocol https://news.medxy.ai/zh/age-related-larynx/Medxy AIzh2026-10-11T03:32:40-07:00老年性喉与喉部不对称性：老年发声障碍并不可靠的预测指标 https://news.medxy.ai/ja/83119-2/Medxy AIja2026-10-11T03:32:23-07:00老年性喉および喉頭の非対称性：高齢者の発声障害における信頼性の低い予測指標 https://news.medxy.ai/vi/presbylarynx-laryngeal-asymmetry/Medxy AIvi2026-10-11T03:32:04-07:00Presbylarynx và bất đối xứng thanh quản: Những dấu ấn dự đoán chứng khàn tiếng ở người cao tuổi không đáng tin cậy https://news.medxy.ai/presbylarynx-and-laryngeal-asymmetry-unreliable-predictors-of-dysphonia-in-older-adults/Medxy AIen2026-10-11T03:31:45-07:00Presbylarynx and Laryngeal Asymmetry: Unreliable Predictors of Dysphonia in Older Adults https://news.medxy.ai/zh/laser-steroid-treatment-comparison/Medxy AIzh2026-10-11T03:31:06-07:00门诊蓝激光联合类固醇注射治疗出血性与非出血性声带息肉的疗效比较 https://news.medxy.ai/ja/blue-laser-steroid-treatment/Medxy AIja2026-10-11T03:30:48-07:00外来ブルーレーザー治療とステロイド注射の併用は、出血性声帯ポリープにより有効か？ https://news.medxy.ai/vi/green-laser-therapy-effectiveness/Medxy AIvi2026-10-11T03:30:28-07:00Hiệu quả của liệu pháp laser xanh thực hiện tại phòng khám phối hợp tiêm steroid đối với polyp dây thanh xuất huyết và không xuất huyết https://news.medxy.ai/efficacy-of-office-based-blue-laser-therapy-combined-with-steroid-injection-for-hemorrhagic-versus-nonhemorrhagic-vocal-fold-polyps/Medxy AIen2026-10-11T03:30:10-07:00Efficacy of Office-Based Blue Laser Therapy Combined with Steroid Injection for Hemorrhagic versus Nonhemorrhagic Vocal Fold Polyps https://news.medxy.ai/zh/airway-management-options/Medxy AIzh2026-10-11T03:29:32-07:00喉内手术气道管理怎么选：高流量鼻导管给氧与高频喷射通气的比较 https://news.medxy.ai/ja/airway-management-throat-surgery/Medxy AIja2026-10-11T03:29:17-07:00喉頭内手術の気道管理をどう選ぶか：High-Flow Nasal CannulaとHigh-Frequency Jet Ventilationの比較 https://news.medxy.ai/vi/airway-management-comparison/Medxy AIvi2026-10-11T03:28:58-07:00Kiểm soát đường thở trong phẫu thuật nội thanh quản: so sánh ống thông mũi dòng cao và thông khí phản lực tần số cao https://news.medxy.ai/navigating-airway-management-in-endolaryngeal-surgery-comparing-high-flow-nasal-cannula-and-high-frequency-jet-ventilation/Medxy AIen2026-10-11T03:28:41-07:00Navigating Airway Management in Endolaryngeal Surgery: Comparing High-Flow Nasal Cannula and High-Frequency Jet Ventilation https://news.medxy.ai/zh/83105-2/Medxy AIzh2026-10-11T03:28:04-07:00外科患者采用虚拟戒烟项目的效果 https://news.medxy.ai/ja/virtual-smoking-cessation/Medxy AIja2026-10-11T03:27:48-07:00外科患者における仮想禁煙プログラムの効果を検証：課題と示唆 https://news.medxy.ai/vi/online-smoking-cessation-impact/Medxy AIvi2026-10-11T03:27:28-07:00Đánh giá tác động của chương trình cai thuốc lá trực tuyến ở người bệnh phẫu thuật: Những thách thức và nhận định https://news.medxy.ai/evaluating-the-impact-of-a-virtual-tobacco-cessation-program-in-surgical-patients-challenges-and-insights/Medxy AIen2026-10-11T03:27:11-07:00Evaluating the Impact of a Virtual Tobacco Cessation Program in Surgical Patients: Challenges and Insights https://news.medxy.ai/zh/abdominal-cancer-palliative-care/Medxy AIzh2026-10-11T03:26:30-07:00腹部癌症手术患者早期姑息治疗能否改善临终结局？SOPE试验带来的启示 https://news.medxy.ai/ja/early-palliative-care-impact/Medxy AIja2026-10-11T03:26:14-07:00外科がん患者における早期緩和ケアの終末期転帰への影響を検証する：SOPE試験から得られた知見 https://news.medxy.ai/vi/early-palliative-care-impact-2/Medxy AIvi2026-10-11T03:25:56-07:00Đánh giá tác động của chăm sóc giảm nhẹ sớm đối với kết cục cuối đời ở bệnh nhân ung thư phẫu thuật: Góc nhìn từ thử nghiệm SOPE https://news.medxy.ai/evaluating-early-palliative-care-impact-on-end-of-life-outcomes-in-surgical-cancer-patients-insights-from-the-sope-trial/Medxy AIen2026-10-11T03:25:38-07:00Evaluating Early Palliative Care Impact on End-of-Life Outcomes in Surgical Cancer Patients: Insights from the SOPE Trial https://news.medxy.ai/zh/roboscore-prediction-comparison/Medxy AIzh2026-10-11T03:25:00-07:00PD-ROBOSCORE被证实可稳健预测胰十二指肠切除术后的严重并发症：开腹与机器人辅助手术的比较启示 https://news.medxy.ai/ja/pd-roboscore-prediction/Medxy AIja2026-10-11T03:24:44-07:00PD-ROBOSCOREは膵頭十二指腸切除術後の重篤な罹患を予測する堅牢な指標と確認：開腹手術とロボット支援手術の比較から https://news.medxy.ai/vi/pd-roboscore-predicts-complications/Medxy AIvi2026-10-11T03:24:27-07:00PD-ROBOSCORE được xác thực là yếu tố dự đoán tin cậy biến chứng nặng sau phẫu thuật cắt tá tụy–tá tràng: so sánh giữa phẫu thuật mở và phẫu thuật robot https://news.medxy.ai/pd-roboscore-validated-as-a-robust-predictor-of-major-morbidity-after-pancreaticoduodenectomy-comparative-insights-into-open-and-robotic-approaches/Medxy AIen2026-10-11T03:24:09-07:00PD-ROBOSCORE Validated as a Robust Predictor of Major Morbidity After Pancreaticoduodenectomy: Comparative Insights into Open and Robotic Approaches https://news.medxy.ai/zh/high-risk-neuroblastoma/Medxy AIzh2026-10-11T03:23:12-07:00高危神经母细胞瘤中，原发灶完全切除显著改善生存：COG ANBL0532试验解析 https://news.medxy.ai/ja/high-risk-neuroblastoma-2/Medxy AIja2026-10-11T03:22:55-07:00高リスク神経芽腫で原発腫瘍の完全切除が生存を改善：COG ANBL0532試験からの知見 https://news.medxy.ai/vi/tumor-removal-survival/Medxy AIvi2026-10-11T03:22:36-07:00Cắt bỏ hoàn toàn khối u giúp cải thiện sống còn ở u nguyên bào thần kinh nguy cơ cao: Kết quả từ thử nghiệm COG ANBL0532 https://news.medxy.ai/complete-surgical-resection-enhances-survival-in-high-risk-neuroblastoma-insights-from-cog-anbl0532-trial/Medxy AIen2026-10-11T03:22:17-07:00Complete Surgical Resection Enhances Survival in High-Risk Neuroblastoma: Insights from COG ANBL0532 Trial https://news.medxy.ai/zh/robotic-pancreatic-surgery/Medxy AIzh2026-10-11T03:21:37-07:00泛欧洲协作培训助力机器人胰十二指肠切除术的安全开展与疗效提升 https://news.medxy.ai/ja/robot-assisted-pancreaticoduodenectomy/Medxy AIja2026-10-11T03:21:21-07:00ロボット支援膵頭十二指腸切除術の安全性と成績を高める汎欧州協働トレーニング https://news.medxy.ai/vi/european-robotic-pancreatectomy-training/Medxy AIvi2026-10-11T03:21:01-07:00Đào tạo liên châu Âu giúp nâng cao an toàn và kết cục trong cắt tá tụy đầu bằng robot https://news.medxy.ai/pan-european-collaborative-training-elevates-safety-and-outcomes-in-robotic-pancreatoduodenectomy/Medxy AIen2026-10-11T03:20:41-07:00Pan-European Collaborative Training Elevates Safety and Outcomes in Robotic Pancreatoduodenectomy https://news.medxy.ai/zh/cgm-ogtt-comparison/Medxy AIzh2026-10-11T03:20:00-07:00早期1型糖尿病中CGM与OGTT：预测准确性及临床启示对比 https://news.medxy.ai/ja/cgm-ogtt-comparison-2/Medxy AIja2026-10-11T03:19:40-07:00早期1型糖尿病の進行予測におけるCGMとOGTTの比較：予測精度と臨床的意義 https://news.medxy.ai/vi/cgm-vs-ogtt-type-1/Medxy AIvi2026-10-11T03:19:19-07:00CGM so với OGTT trong đái tháo đường týp 1 giai đoạn sớm: Độ chính xác dự đoán so sánh và ý nghĩa lâm sàng https://news.medxy.ai/cgm-versus-ogtt-in-early-stage-type-1-diabetes-comparative-predictive-accuracy-and-clinical-implications/Medxy AIen2026-10-11T03:18:58-07:00CGM Versus OGTT in Early-Stage Type 1 Diabetes: Comparative Predictive Accuracy and Clinical Implications https://news.medxy.ai/biallelic-cyb5a-disruptions-in-46-xy-disorders-of-sex-development-novel-missense-and-deep-intronic-variants-in-two-vietnamese-siblings/Medxy AIen2026-10-11T03:18:07-07:00Biallelic CYB5A Disruptions in 46, XY Disorders of Sex Development: Novel Missense and Deep Intronic Variants in Two Vietnamese Siblings https://news.medxy.ai/zh/tbx2-vascular-calcification-2/Medxy AIzh2026-10-11T03:17:25-07:00揭示TBX2：慢性肾脏病中血管钙化的核心调控因子 https://news.medxy.ai/ja/tbx2-ckd-calcium/Medxy AIja2026-10-11T03:17:06-07:00CKDにおける血管石灰化の中枢制御因子TBX2を解き明かす https://news.medxy.ai/vi/tbx2-vascular-calcification/Medxy AIvi2026-10-11T03:16:42-07:00TBX2 được hé lộ: Bộ điều hòa trung tâm của vôi hóa mạch máu trong bệnh thận mạn https://news.medxy.ai/unveiling-tbx2-a-master-regulator-of-vascular-calcification-in-chronic-kidney-disease/Medxy AIen2026-10-11T03:16:20-07:00Unveiling TBX2: A Master Regulator of Vascular Calcification in Chronic Kidney Disease https://news.medxy.ai/three-year-follow-up-of-lisocabtagene-maraleucel-demonstrates-durable-remission-and-manageable-safety-in-relapsed-refractory-follicular-lymphoma/Medxy AIen2026-10-11T03:13:37-07:00Three-Year Follow-Up of Lisocabtagene Maraleucel Demonstrates Durable Remission and Manageable Safety in Relapsed/Refractory Follicular Lymphoma https://news.medxy.ai/zh/bevacizumab-vs-laser-rop/Medxy AIzh2026-10-10T04:22:04-07:00早产儿视网膜病变中玻璃体腔注射贝伐珠单抗与激光治疗的比较：再次治疗率、时机及风险预测因素分析 https://news.medxy.ai/ja/retinopathy-treatment-comparison/Medxy AIja2026-10-10T04:21:45-07:00未熟児網膜症に対する硝子体内ベバシズマブとレーザー治療の比較：再治療率、実施時期、およびリスク予測因子の解析 https://news.medxy.ai/vi/bevacizumab-vs-laser/Medxy AIvi2026-10-10T04:21:25-07:00Bevacizumab nội nhãn so với quang đông laser trong bệnh võng mạc trẻ đẻ non: phân tích tỷ lệ, thời điểm và yếu tố dự báo điều trị lại https://news.medxy.ai/intravitreal-bevacizumab-versus-laser-therapy-in-retinopathy-of-prematurity-analyzing-retreatment-rates-timing-and-risk-predictors/Medxy AIen2026-10-10T04:21:08-07:00Intravitreal Bevacizumab versus Laser Therapy in Retinopathy of Prematurity: Analyzing Retreatment Rates, Timing, and Risk Predictors https://news.medxy.ai/zh/bietti-retinopathy-3d-structure/Medxy AIzh2026-10-10T04:06:58-07:00揭示 Bietti 晶状体样营养不良中外层视网膜管状结构的复杂三维架构 https://news.medxy.ai/ja/bietti-retinopathy-architecture/Medxy AIja2026-10-10T04:06:42-07:00Bietti結晶様視網膜ジストロフィーにおける外網膜管状構造の三次元アーキテクチャを解明する https://news.medxy.ai/vi/bietti-retinal-tubes/Medxy AIvi2026-10-10T04:06:20-07:00Giải mã kiến trúc ba chiều phức tạp của ống hóa võng mạc ngoài trong loạn dưỡng thể tinh thể Bietti https://news.medxy.ai/unraveling-the-complex-3d-architecture-of-outer-retinal-tubulation-in-bietti-crystalline-dystrophy/Medxy AIen2026-10-10T04:06:00-07:00Unraveling the Complex 3D Architecture of Outer Retinal Tubulation in Bietti Crystalline Dystrophy https://news.medxy.ai/zh/subglottic-stenosis-pregnancy/Medxy AIzh2026-10-10T04:05:23-07:00妊娠期特发性声门下狭窄：病例对照研究揭示安全性、临床过程与管理要点 https://news.medxy.ai/ja/laryngeal-stenosis-pregnancy/Medxy AIja2026-10-10T04:05:06-07:00妊娠中の特発性声門下狭窄症：症例対照研究が示す安全性、臨床経過、治療の要点 https://news.medxy.ai/vi/idiopathic-subglottic-stenosis-pregnancy/Medxy AIvi2026-10-10T04:04:44-07:00Hẹp dưới thanh môn vô căn trong thai kỳ: Mức độ an toàn, diễn tiến lâm sàng và kinh nghiệm xử trí từ nghiên cứu bệnh-chứng https://news.medxy.ai/idiopathic-subglottic-stenosis-in-pregnancy-safety-clinical-course-and-management-insights-from-a-case-control-study/Medxy AIen2026-10-10T04:04:27-07:00Idiopathic Subglottic Stenosis in Pregnancy: Safety, Clinical Course, and Management Insights from a Case-Control Study https://news.medxy.ai/zh/thyroid-parathyroid-pneumothorax/Medxy AIzh2026-10-10T04:03:47-07:00甲状腺与甲状旁腺手术后气胸：少见却高风险 https://news.medxy.ai/ja/rare-thoracic-complication/Medxy AIja2026-10-10T04:03:31-07:00見逃せない稀な合併症：甲状腺・副甲状腺手術後気胸の臨床的意義 https://news.medxy.ai/vi/pneumothorax-after-thyroid-surgery/Medxy AIvi2026-10-10T04:03:14-07:00Hiếm nhưng nguy hiểm: Ý nghĩa lâm sàng của tràn khí màng phổi sau cắt tuyến giáp và tuyến cận giáp https://news.medxy.ai/rare-but-risky-clinical-implications-of-pneumothorax-following-thyroidectomy-and-parathyroidectomy/Medxy AIen2026-10-10T04:02:58-07:00Rare But Risky: Clinical Implications of Pneumothorax Following Thyroidectomy and Parathyroidectomy https://news.medxy.ai/zh/surgical-pathway-shift/Medxy AIzh2026-10-10T04:02:22-07:00手术路径的转变：某科室由全扁桃体切除术迈向囊内扁桃体切除术的经验与启示 https://news.medxy.ai/ja/tonsillectomy-shift/Medxy AIja2026-10-10T04:02:06-07:00扁桃摘出術の転換を読み解く：全摘から被膜内へ移行した診療科の知見 https://news.medxy.ai/vi/tonsillectomy-transition-key-factors/Medxy AIvi2026-10-10T04:01:45-07:00Từ cắt amidan toàn bộ đến cắt amidan trong bao: Những yếu tố then chốt trong quá trình chuyển đổi của một khoa https://news.medxy.ai/navigating-the-shift-insights-into-a-departments-transition-from-total-to-intracapsular-tonsillectomy/Medxy AIen2026-10-10T04:01:27-07:00Navigating the Shift: Insights into a Department’s Transition from Total to Intracapsular Tonsillectomy https://news.medxy.ai/zh/post-pancreatectomy-bleeding/Medxy AIzh2026-10-10T04:00:40-07:00揭开胰腺切除术后出血的面纱：基于大样本队列分析的出血来源、隐源性事件及严重程度预测因素 https://news.medxy.ai/ja/post-pancreatectomy-bleeding-3/Medxy AIja2026-10-10T04:00:22-07:00膵切除後出血の実像を読み解く：大規模コホートが示した出血源、原因不明例、重症化予測因子 https://news.medxy.ai/vi/post-pancreatectomy-bleeding-2/Medxy AIvi2026-10-10T04:00:00-07:00Làm rõ xuất huyết sau cắt tụy: nguồn chảy máu, biến cố vô căn và các yếu tố dự báo mức độ nặng từ phân tích một đoàn hệ lớn https://news.medxy.ai/unveiling-postpancreatectomy-hemorrhage-bleeding-sources-cryptogenic-events-and-predictors-of-severity-from-a-large-cohort-analysis/Medxy AIen2026-10-10T03:59:38-07:00Unveiling Postpancreatectomy Hemorrhage: Bleeding Sources, Cryptogenic Events, and Predictors of Severity from a Large Cohort Analysis https://news.medxy.ai/zh/quantifying-surgeon-intuition/Medxy AIzh2026-10-10T03:59:00-07:00量化外科医生直觉：视觉模拟量表能否预测术后结局 https://news.medxy.ai/ja/82984-2/Medxy AIja2026-10-10T03:58:43-07:00外科医の直感を定量化する：視覚的アナログスケールは術後転帰を予測できるか https://news.medxy.ai/vi/surgeon-intuition-scale/Medxy AIvi2026-10-10T03:58:25-07:00Định lượng trực giác của phẫu thuật viên: Thang đo tương tự thị giác trong dự báo kết cục sau mổ https://news.medxy.ai/surgeon-intuition/Medxy AIen2026-10-10T03:58:08-07:00Quantifying the Surgeon’s Intuition: Visual Analog Scale as a Predictor of Postoperative Outcomes https://news.medxy.ai/zh/icg-liver-resection/Medxy AIzh2026-10-10T03:57:32-07:00吲哚菁绿荧光助力结直肠癌肝转移微创保肝切除：SICE Liver ICG研究解读 https://news.medxy.ai/ja/icg-liver-resection-2/Medxy AIja2026-10-10T03:57:15-07:00ICG蛍光で高める大腸癌肝転移に対する低侵襲肝切除の精度――SICE Liver ICG studyからの知見 https://news.medxy.ai/vi/liver-cutting-fluorescence/Medxy AIvi2026-10-10T03:56:55-07:00Nâng cao độ chính xác trong cắt gan ít xâm lấn đối với di căn đại trực tràng bằng huỳnh quang indocyanine green: Những phát hiện từ nghiên cứu SICE Liver ICG https://news.medxy.ai/enhancing-precision-in-minimally-invasive-liver-resection-for-colorectal-metastases-using-indocyanine-green-fluorescence-insights-from-the-sice-liver-icg-study/Medxy AIen2026-10-10T03:56:35-07:00Enhancing Precision in Minimally Invasive Liver Resection for Colorectal Metastases Using Indocyanine Green Fluorescence: Insights from the SICE Liver ICG Study https://news.medxy.ai/zh/multidisciplinary-survivorship-clinic/Medxy AIzh2026-10-10T03:55:55-07:00多学科晚期后遗症门诊在低位前切除综合征管理中的应用：一项前瞻性队列研究 https://news.medxy.ai/ja/lars-management/Medxy AIja2026-10-10T03:55:40-07:00直腸癌術後LARSの管理における多職種晩期後遺症外来：前向きコホート研究 https://news.medxy.ai/vi/post-rheumatic-complications/Medxy AIvi2026-10-10T03:55:24-07:00Phòng khám di chứng muộn đa chuyên khoa trong quản lý Hội chứng sau cắt trước thấp: Nghiên cứu đoàn hệ tiến cứu https://news.medxy.ai/multidisciplinary-late-sequelae-clinics-in-managing-low-anterior-resection-syndrome-a-prospective-cohort-study/Medxy AIen2026-10-10T03:55:08-07:00Multidisciplinary Late Sequelae Clinics in Managing Low Anterior Resection Syndrome: A Prospective Cohort Study https://news.medxy.ai/zh/82963-2/Medxy AIzh2026-10-10T03:54:33-07:00青少年腹股沟疝修补术后的长期慢性疼痛与性功能障碍：一项丹麦全国性调查的启示 https://news.medxy.ai/ja/82961-2/Medxy AIja2026-10-10T03:54:18-07:00思春期の鼠径ヘルニア修復術後の長期にわたる慢性疼痛および性機能障害：デンマークの全国調査からの知見 https://news.medxy.ai/vi/chronic-pain-sexual-dysfunction/Medxy AIvi2026-10-10T03:53:57-07:00Đau mạn tính kéo dài và rối loạn chức năng tình dục sau sửa thoát vị bẹn ở thanh thiếu niên: Góc nhìn từ khảo sát toàn quốc tại Đan Mạch https://news.medxy.ai/long-term-chronic-pain-and-sexual-dysfunction-after-adolescent-groin-hernia-repair-insights-from-a-danish-nationwide-survey/Medxy AIen2026-10-10T03:53:40-07:00Long-Term Chronic Pain and Sexual Dysfunction After Adolescent Groin Hernia Repair: Insights from a Danish Nationwide Survey https://news.medxy.ai/zh/closing-gun-law-gap/Medxy AIzh2026-10-10T03:53:01-07:00弥补枪支立法缺口：减少美国11万例可预防的枪支自杀死亡 https://news.medxy.ai/ja/gun-law-gap/Medxy AIja2026-10-10T03:52:46-07:00銃器規制の法的空白を埋める：全米で回避可能な11万件の銃器自殺を減らすために https://news.medxy.ai/vi/gun-law-gaps/Medxy AIvi2026-10-10T03:52:27-07:00Lấp đầy khoảng trống pháp luật về súng: giảm 110.000 ca tự sát bằng súng có thể phòng tránh trên toàn nước Mỹ https://news.medxy.ai/bridging-the-firearm-law-gaps-reducing-110000-preventable-firearm-suicides-across-the-u-s/Medxy AIen2026-10-10T03:52:10-07:00Bridging the Firearm Law Gaps: Reducing 110,000 Preventable Firearm Suicides Across the U.S. https://news.medxy.ai/zh/farletuzumab-eceteribulin/Medxy AIzh2026-10-10T03:51:02-07:00Farletuzumab Ecteribulin：在靶向叶酸受体α的同时优化给药，以降低晚期癌症中的肺毒性 https://news.medxy.ai/ja/farletuzumab-optimization/Medxy AIja2026-10-10T03:50:45-07:00Farletuzumab ecteribulin：進行がんにおけるFRα標的化と肺毒性軽減を両立する投与最適化 https://news.medxy.ai/vi/farletuzumab-eceteribulin-dose-optimization/Medxy AIvi2026-10-10T03:50:25-07:00Farletuzumab Ecteribulin: Tối ưu hóa liều để giảm độc tính phổi khi nhắm vào folate receptor alpha trong các ung thư tiến triển https://news.medxy.ai/farletuzumab-ecteribulin-optimizing-dosing-to-mitigate-lung-toxicity-while-targeting-folate-receptor-alpha-in-advanced-cancers/Medxy AIen2026-10-10T03:50:07-07:00Farletuzumab Ecteribulin: Optimizing Dosing to Mitigate Lung Toxicity While Targeting Folate Receptor Alpha in Advanced Cancers https://news.medxy.ai/zh/bridging-menopause-knowledge-gap/Medxy AIzh2026-10-10T03:49:29-07:00弥合知识缺口：提升临床医生的绝经教育 https://news.medxy.ai/ja/menopause-education-gap/Medxy AIja2026-10-10T03:49:15-07:00閉経教育の格差を埋める：臨床医のための学習強化 https://news.medxy.ai/vi/82930-2/Medxy AIvi2026-10-10T03:48:59-07:00Thu hẹp khoảng cách trong giáo dục về mãn kinh: Tăng cường đào tạo cho bác sĩ lâm sàng https://news.medxy.ai/bridging-the-knowledge-gap-enhancing-menopause-education-for-clinicians/Medxy AIen2026-10-10T03:48:42-07:00Bridging the Knowledge Gap: Enhancing Menopause Education for Clinicians https://news.medxy.ai/zh/endometrial-cancer-race-ethnicity/Medxy AIzh2026-10-10T03:48:05-07:00子宫内膜癌治疗启动与生存的种族及族裔差异：社会经济调节因素与临床启示 https://news.medxy.ai/ja/endometrial-cancer-disparities/Medxy AIja2026-10-10T03:47:44-07:00子宮内膜癌における治療開始と生存の人種・民族格差：社会経済的修飾因子と臨床的含意 https://news.medxy.ai/vi/racial-ethnic-disparities-cancer/Medxy AIvi2026-10-10T03:47:19-07:00Chênh lệch chủng tộc và sắc tộc trong khởi trị điều trị và sống còn ở bệnh nhân ung thư nội mạc tử cung: Vai trò của các yếu tố kinh tế – xã hội và hàm ý lâm sàng https://news.medxy.ai/racial-and-ethnic-disparities-in-treatment-initiation-and-survival-among-patients-with-endometrial-cancer-socioeconomic-modifiers-and-clinical-implications/Medxy AIen2026-10-10T03:46:58-07:00Racial and Ethnic Disparities in Treatment Initiation and Survival Among Patients With Endometrial Cancer: Socioeconomic Modifiers and Clinical Implications https://news.medxy.ai/zh/masld-risk-regulation/Medxy AIzh2026-10-10T03:46:11-07:00PNPLA3I148M 携带者 MASLD 风险的调控：肠道菌群与神经酰胺的作用 https://news.medxy.ai/ja/pnpla3-masld-risk/Medxy AIja2026-10-10T03:45:55-07:00PNPLA3I148M保有者のMASLDリスクをどう制御するか：腸内細菌叢とセラミドの役割 https://news.medxy.ai/vi/masld-risk-pnpla3/Medxy AIvi2026-10-10T03:45:36-07:00Điều biến nguy cơ MASLD ở người mang PNPLA3I148M: Vai trò của hệ vi sinh đường ruột và ceramide https://news.medxy.ai/modulating-masld-risk-in-pnpla3i148m-carriers-the-role-of-gut-microbiota-and-ceramides/Medxy AIen2026-10-10T03:45:18-07:00Modulating MASLD Risk in PNPLA3I148M Carriers: The Role of Gut Microbiota and Ceramides https://news.medxy.ai/zh/82917-2/Medxy AIzh2026-10-10T03:44:39-07:00解析化疗诱导的周围神经毒性风险：持续性及剂量限制性神经毒性的临床预测指标 https://news.medxy.ai/ja/chemotherapy-neurotoxicity/Medxy AIja2026-10-10T03:44:20-07:00化学療法誘発末梢神経毒性を読み解く：用量制限性および持続性神経毒性を左右する臨床予測因子 https://news.medxy.ai/vi/82913-2/Medxy AIvi2026-10-10T03:43:58-07:00Giải mã các nguy cơ gây độc thần kinh ngoại biên do hóa trị: Các yếu tố lâm sàng dự báo độc tính thần kinh dai dẳng và độc tính giới hạn liều https://news.medxy.ai/decoding-risks-of-chemotherapy-induced-peripheral-neurotoxicity-clinical-predictors-of-dose-limiting-and-persistent-neurologic-toxicity/Medxy AIen2026-10-10T03:43:38-07:00Decoding Risks of Chemotherapy-Induced Peripheral Neurotoxicity: Clinical Predictors of Dose-Limiting and Persistent Neurologic Toxicity https://news.medxy.ai/zh/82907-2/Medxy AIzh2026-10-10T03:42:52-07:00心脏骤停后超难治性癫痫持续状态的双重抗谷氨酸治疗：基于 SUPER-CAT 研究及现有证据的见解 https://news.medxy.ai/ja/super-cat-epilepsy-treatment/Medxy AIja2026-10-10T03:42:32-07:00心停止後の超難治性てんかん重積状態に対する二重抗グルタミン酸療法：SUPER-CAT研究と最新エビデンスからの示唆 https://news.medxy.ai/vi/dual-glutamate-therapy/Medxy AIvi2026-10-10T03:42:07-07:00Liệu pháp kháng glutamate kép trong trạng thái động kinh kháng trị siêu nặng sau ngừng tim: Góc nhìn từ nghiên cứu SUPER-CAT và bằng chứng hiện có https://news.medxy.ai/dual-antiglutamate-therapy-in-super-refractory-status-epilepticus-after-cardiac-arrest-insights-from-the-super-cat-study-and-current-evidence/Medxy AIen2026-10-10T03:41:43-07:00Dual Antiglutamate Therapy in Super-Refractory Status Epilepticus After Cardiac Arrest: Insights from the SUPER-CAT Study and Current Evidence https://news.medxy.ai/zh/82898-2/Medxy AIzh2026-10-10T03:40:51-07:00阿尔茨海默病中血浆 pTau217（Lumipulse G 检测）与颞叶皮层病理改变之间的定量关系 https://news.medxy.ai/ja/82896-2/Medxy AIja2026-10-10T03:40:32-07:00アルツハイマー病における血漿中pTau217のLumipulse G測定値と側頭葉皮質の病理学的変化との量的関係 https://news.medxy.ai/vi/ptau217-alzheimer-link/Medxy AIvi2026-10-10T03:40:07-07:00Mối liên hệ định lượng giữa pTau217 đo bằng Lumipulse G trong huyết tương và bệnh lý vỏ não thái dương trong bệnh Alzheimer https://news.medxy.ai/quantitative-relationship-between-lumipulse-g-measures-of-ptau217-in-plasma-and-temporal-cortex-pathology-in-alzheimer-disease/Medxy AIen2026-10-10T03:39:46-07:00Quantitative Relationship Between Lumipulse G Measures of pTau217 in Plasma and Temporal Cortex Pathology in Alzheimer Disease https://news.medxy.ai/zh/ocrelizumab-ms-insights/Medxy AIzh2026-10-10T03:38:54-07:00复发型多发性硬化中奥瑞珠单抗10年治疗的启示：来自OPERA I和II随机临床试验及相关证据 https://news.medxy.ai/ja/ocrelizumab-ms-10years/Medxy AIja2026-10-10T03:38:34-07:00再発型多発性硬化症におけるオクリズマブ10年の軌跡：OPERA I・II無作為化臨床試験と関連エビデンスからの知見 https://news.medxy.ai/vi/ocrelizumab-ms-trials/Medxy AIvi2026-10-10T03:38:12-07:00Ocrelizumab trong bệnh đa xơ cứng tái phát sau 10 năm: Những phát hiện từ các thử nghiệm lâm sàng ngẫu nhiên OPERA I và II và bằng chứng liên quan https://news.medxy.ai/ten-years-of-ocrelizumab-in-relapsing-multiple-sclerosis-insights-from-the-opera-i-and-ii-randomized-clinical-trials-and-related-evidence/Medxy AIen2026-10-10T03:37:51-07:00Ten Years of Ocrelizumab in Relapsing Multiple Sclerosis: Insights from the OPERA I and II Randomized Clinical Trials and Related Evidence https://news.medxy.ai/ja/vascular-imaging-guidelines/Medxy AIja2026-10-10T03:36:55-07:00カテ室の好奇心からガイドラインの必須項目へ：血管内イメージングはいかに複雑PCIの要となったか https://news.medxy.ai/vi/pci-imaging/Medxy AIvi2026-10-10T03:36:24-07:00Từ tò mò trong phòng thông tim đến yêu cầu bắt buộc của hướng dẫn: vì sao chẩn đoán hình ảnh trong lòng mạch trở thành trụ cột của PCI phức tạp https://news.medxy.ai/zh/intravascular-imaging-core/Medxy AIzh2026-10-10T03:35:56-07:00从导管室的新奇工具到指南硬性要求：血管内影像如何成为复杂PCI的核心 https://news.medxy.ai/from-cath-lab-curiosity-to-guideline-mandate-how-intravascular-imaging-became-essential-for-complex-pci/Medxy AIen2026-10-10T03:35:29-07:00From Cath Lab Curiosity to Guideline Mandate: How Intravascular Imaging Became Essential for Complex PCI https://news.medxy.ai/zh/conduction-pacing-vs-biventricular/Medxy AIzh2026-10-10T03:34:16-07:00房室结消融后：传导系统起搏与双心室起搏谁更优？CONDUCT-AF试验带来新启示 https://news.medxy.ai/ja/av-nodal-ablation-pacing/Medxy AIja2026-10-10T03:33:58-07:00心不全合併心房細動におけるAV結節アブレーション後の伝導系ペーシングと両心室ペーシング：CONDUCT-AF試験が示した知見